MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 182 filers reported holding MEDICINES CO in Q4 2013. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $27,630,000 | +134.2% | 325,297 | +37.8% | 0.21% | +135.2% |
| Q3 2019 | $11,800,000 | +303.8% | 236,002 | +194.5% | 0.09% | +333.3% |
| Q2 2019 | $2,922,000 | +219.3% | 80,128 | +144.8% | 0.02% | +162.5% |
| Q1 2019 | $915,000 | +129.9% | 32,733 | +57.3% | 0.01% | +100.0% |
| Q4 2018 | $398,000 | -55.4% | 20,815 | -30.3% | 0.00% | -33.3% |
| Q3 2018 | $893,000 | -54.0% | 29,870 | -43.5% | 0.01% | -45.5% |
| Q2 2018 | $1,941,000 | +217.7% | 52,900 | +323.2% | 0.01% | +120.0% |
| Q1 2017 | $611,000 | -47.5% | 12,500 | -59.4% | 0.01% | -16.7% |
| Q3 2016 | $1,163,000 | +305.2% | 30,808 | +241.3% | 0.01% | +200.0% |
| Q1 2016 | $287,000 | -90.5% | 9,027 | -88.9% | 0.00% | -88.2% |
| Q4 2015 | $3,035,000 | +629.6% | 81,300 | +642.5% | 0.02% | +750.0% |
| Q3 2015 | $416,000 | +68.4% | 10,950 | +26.8% | 0.00% | +100.0% |
| Q2 2015 | $247,000 | -91.6% | 8,633 | -91.7% | 0.00% | -93.8% |
| Q1 2015 | $2,929,000 | +463.3% | 104,556 | +675.9% | 0.02% | +433.3% |
| Q4 2013 | $520,000 | – | 13,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |